Key result
High TyG-BMI is linked to a ~5-fold higher risk of LVH in hypertensive adults.
Why the study?
Hypertension-induced left ventricular hypertrophy is linked to insulin resistance, prompting evaluation of the relationship between four advanced insulin resistance surrogates and left ventricular hypertrophy in hypertensive cohorts.
Do insulin resistance surrogates (TyG, TyG-BMI, TG/HDL-c, METS-IR) predict the presence of left ventricular hypertrophy in hypertensive adults?
Case-Control (n=603)
No
Do insulin resistance surrogates (TyG, TyG-BMI, TG/HDL-c, METS-IR) predict the presence of left ventricular hypertrophy in hypertensive adults?
Odds Ratio: 5.211 (95% CI 2.861–9.492)
p-value: p=<0.05
TyG-BMI and METS-IR are strong, independent predictors of left ventricular hypertrophy in hypertensive patients, offering accessible clinical markers for cardiovascular risk stratification.
TyG-BMI may support LVH risk stratification in hypertension; leaves open incremental predictive value beyond standard factors in prospective cohorts.
Background: Hypertension-induced left ventricular hypertrophy (LVH) is intricately linked to insulin resistance (IR). This research aimed to elucidate the relationship of advanced indices, namely the triglyceride-glucose (TyG) index, the TyG adjusted for body mass index (TyG-BMI), the triglycerides-to-high-density lipoprotein cholesterol ratio (TG/HDL-c), and the metabolic score for IR (METS-IR), with LVH in hypertensive cohorts. Methods: This analytical case-control investigation encompassed 800 individuals aged 18 or above from the Cardiology Department of the Second Affiliated Hospital of Baotou Medical College over a span from January 2021 to April 2022. Data extraction was conducted from inpatient records. The nexus between the four metrics and LVH susceptibility was ascertained via logistic regression models. Furthermore, the receiver operating characteristic (ROC) curve's area (AUC) shed light on the discriminative capacities of the distinct IR indicators for LVH, considering other concomitant risk variables. Results: Post multifaceted covariate adjustments, the fourth quartile figures for TyG-BMI emerged as the most starkly significant (OR: 5.211, 95% CI: 2.861-9.492), succeeded by METS-IR (OR: 4.877, 95% CI: 2.693-8.835). In juxtaposition with other IR-derived indices (TyG and TG/HDL-c), TyG-BMI manifested the paramount AUC (AUC: 0.657; 95% CI: 0.606-0.708). Concurrently, METS-IR exhibited commendable predictive efficacy for LVH (AUC: 0.646; 95% CI: 0.595-0.697). Conclusion: TyG-BMI and METS-IR displayed superior discriminative capabilities for LVH, underscoring their potential as supplementary indicators in gauging LVH peril in clinical settings and prospective epidemiological research.
No takes yet. Share an insight, caveat, or question.
Zhai et al. (2024) conducted a case-control in Hypertension with or without Left Ventricular Hypertrophy (LVH) (n=603). TyG-BMI (Triglyceride-glucose index adjusted for body mass index) vs. Lowest quartile of TyG-BMI was evaluated on Presence of Left Ventricular Hypertrophy (LVH) (OR 5.211, 95% CI 2.861-9.492, p=<0.05). The highest quartile of the TyG-BMI index was strongly associated with an increased risk of left ventricular hypertrophy in hypertensive adults (OR 5.211).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: